Rapid Micro Biosystems Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 126.5% | 102.7% | 127.1% | 102.9% | 91.8% | 88.1% | 94.4% | 73.2% | 71.0% | 102.9% | 95.4% | 85.0% | 90.0% | |
| -26.5% | -2.7% | -27.1% | -2.9% | 8.2% | 11.9% | 5.6% | 26.8% | 29.0% | -2.9% | 4.6% | 15.0% | 10.0% | |
| 50.7% | 52.4% | 68.5% | 56.6% | 47.5% | 41.4% | 50.3% | 44.5% | 45.0% | 28.5% | 42.0% | 41.4% | 38.2% | |
| 101.0% | 87.4% | 100.3% | 87.9% | 74.6% | 58.7% | 79.0% | 83.7% | 72.0% | 47.3% | 93.0% | 84.0% | 71.6% | |
| 208.6% | 189.6% | 227.2% | 199.3% | 166.5% | 136.4% | 167.5% | 194.1% | 174.1% | 105.3% | 177.7% | 168.0% | 151.5% | |
| -235.1% | -192.3% | -254.4% | -202.1% | -158.3% | -124.5% | -161.8% | -167.3% | -145.1% | -108.2% | -173.1% | -153.0% | -141.5% | |
| – | 15.7% | – | – | 0.1% | – | 0.2% | 0.2% | 5.3% | 7.2% | 8.0% | 8.0% | 7.1% | |
| -217.8% | -176.2% | -237.4% | -189.8% | -148.7% | -117.7% | -156.2% | -163.1% | -146.7% | -110.7% | -178.3% | -159.9% | -145.3% | |
| 0.2% | 0.1% | 0.1% | 0.2% | 0.2% | -0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.6% | 0.2% | |
| -217.9% | -176.3% | -237.4% | -190.1% | -148.9% | -117.6% | -156.3% | -163.3% | -146.8% | -110.8% | -178.4% | -160.5% | -145.6% | |
| -206.7% | -163.6% | -224.8% | -177.3% | -139.2% | -107.2% | -144.5% | -152.0% | -131.1% | -96.5% | -161.5% | -151.9% | -131.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.